Postby rp1954 » Wed Dec 24, 2014 10:44 am
Don't panic. I would stay on track with current ADAPT treatments until you can find tweaks, information, or major changes. A tweak might be a minor addition, like more vit D3, PSK, cimetidine or perhaps nutritive adjunct.
Even if something were growing the objective should be to stop or slow it down, and most importantly, stop any new metastasis (continuous chemo, cimetidine etc) until any spots can be cut or punched out. One possibility is that your DH is essentially dynamically stable, something growing and then popping, releasing biomarkers and coagulation factors. If that's the case, we monitor for preliminary signs of hypercoagulability too, like shortened PT/INR and aPTT times. If PT and/or aPTT are short we're going to look for treatment adjustments and/or more formal coagulation lab tests and coagulation adjustments.
CEA changes might be partly smoke or DM/sugar influenced or other variables, although taking them seriously is part of the contingencies here.
The SUV 3.6 shouldn't be ignored but it's still pretty low activity. I would interview some and size up surgeons for that potential site.
When we're not sure, we do more blood tests (e.g. CA19-9, ESR, LDH added), more frequently, the blood sample intervals a month or less, or even repeats. Truth is, informed patients can monitor this stuff far closer than the drs can because of longer case dwell time with direct self interest, and fewer artificial data restrictions.
watchful, active researcher and caregiver for stage IVb/c CC. surgeries 4/10 sigmoid etc & 5/11 para-aortic LN cluster; 8 yrs immuno-Chemo for mCRC; now no chemo
most of 2010 Life Extension recommendations and possibilities + more, some (much) higher, peaking ~2011-12, taper chemo to almost nothing mid 2018, IV C-->2021. Now supplements